Morphogenesis Inc. | WebDisclosure

Basculer en Français

9551	Companies
188532	Keywords
120347	Articles
100662	Press releases

Home
Companies
Morphogenesis Inc.

BRIEF

published on 04/25/2024 at 15:05, 1 year 7 months ago

TuHURA Biosciences to Showcase Clinical Trial Results at ASCO 2024

Clinical Trials Mergers And Acquisitions TuHURA Biosciences Cancer Immunotherapy ASCO 2024
BRIEF

published on 04/25/2024 at 15:05, 1 year 7 months ago

TuHURA Biosciences présentera les résultats des essais cliniques à l'ASCO 2024

TuHURA Biosciences Essais Cliniques Fusions Et Acquisitions ASCO 2024 Immunothérapie Anticancéreuse
PRESS RELEASE

published on 04/25/2024 at 15:00, 1 year 7 months ago

TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
TuHURA Biosciences, Inc. announces IFx-2.0 Phase 1b trial results accepted for poster presentation at 2024 ASCO Annual Meeting. Company to form new entity with Kintara Therapeutics, Inc. and focus on cancer vaccines and bi-functional ADCs

Phase 1b Trial TuHURA Biosciences Inc. IFx-2.0 Poster Presentation Kintara Therapeutics Inc.
PRESS RELEASE

published on 12/14/2023 at 16:00, 2 years ago

Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview
PRESS RELEASE

published on 11/08/2023 at 15:00, 2 years 1 month ago

Morphogenesis, Inc. Biomarker Analysis Data from IFx-Hu2.0 in Melanoma Refractory to Anti-PD1-Based Therapies Demonstrates Ability to Overcome Primary Resistance to Checkpoint Inhibitors and Trigger an Innate Immune Response

Accesswire

Published on 12/19/2025 at 01:10, 47 minutes ago

Ostrom Climate Exits Existing UPRIIS ERPA Arrangements
Published on 12/19/2025 at 01:00, 57 minutes ago

Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited
Published on 12/19/2025 at 00:50, 1 hour 7 minutes ago

High Resolution Gravity Survey Targets Challenger Repeats
Published on 12/19/2025 at 00:00, 1 hour 57 minutes ago

LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Published on 12/18/2025 at 23:10, 2 hours 47 minutes ago

Air T, Inc. Announces Closing of Regional Express Acquisition

View all ACCESSWIRE

EQS Group

Published on 12/18/2025 at 22:05, 3 hours 52 minutes ago

Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology
Published on 12/18/2025 at 22:05, 3 hours 52 minutes ago

Abivax to be Added to Nasdaq Biotechnology Index
Published on 12/18/2025 at 20:09, 5 hours 47 minutes ago

EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond
Published on 12/18/2025 at 19:30, 6 hours 27 minutes ago

Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT
Published on 12/18/2025 at 19:30, 6 hours 27 minutes ago

Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST

Les Echos

Published on 12/18/2025 at 18:30, 7 hours 27 minutes ago

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 18:30, 7 hours 27 minutes ago

Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde
Published on 12/18/2025 at 17:45, 8 hours 12 minutes ago

Cie du Bois Sauvage: Vernietiging eigen aandelen
Published on 12/18/2025 at 17:45, 8 hours 12 minutes ago

Damartex réaffirme son éligibilité au PEA-PME
Published on 12/18/2025 at 17:45, 8 hours 12 minutes ago

Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE